4.5 Article

Overview perspective of bacterial resistance

Related references

Note: Only part of the references are listed.
Article Microbiology

Detection of KPC in Acinetobacter spp. in Puerto Rico

Iraida E. Robledo et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Immunology

Development of Reduced Vancomycin Susceptibility in Methicillin-Susceptible Staphylococcus aureus

Satish K. Pillai et al.

CLINICAL INFECTIOUS DISEASES (2009)

Article Immunology

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

Helen W. Boucher et al.

CLINICAL INFECTIOUS DISEASES (2009)

Review Microbiology

AmpC beta-Lactamases

George A. Jacoby

CLINICAL MICROBIOLOGY REVIEWS (2009)

Article Infectious Diseases

The changing epidemiology of resistance

Peter M. Hawkey et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

Article Infectious Diseases

Has the era of untreatable infections arrived?

David M. Livermore

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

Review Infectious Diseases

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

Patrice Nordmann et al.

LANCET INFECTIOUS DISEASES (2009)

Review Infectious Diseases

Clinically significant carbapenemases: an update

Timothy R. Walsh

CURRENT OPINION IN INFECTIOUS DISEASES (2008)

Review Public, Environmental & Occupational Health

2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings

Jane D. Siegel et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2007)

Review Microbiology

Carbapenemases:: the versatile β-lactamases

Anne Marie Queenan et al.

CLINICAL MICROBIOLOGY REVIEWS (2007)

Article Microbiology

First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase

Maria Virginia Villegas et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)